tradingkey.logo
tradingkey.logo
Search

Impact Biomedical Inc

IBO
Add to Watchlist
0.430USD
0.0000.00%
Close 07-31 16:00ETQuotes delayed by 15 min
46.36MMarket Cap
LossP/E TTM

IBO Financials

See Impact Biomedical Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Impact Biomedical Inc Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-0.02/--
Revenue / Forecast
7.00K/--
Period
FY2025 Earnings
Revenue(YoY)
32.00K
--
EPS(YoY)
-0.38
83.66%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Financial Indicators
EPS
79.80%-0.02
102.48%0.06
-132.68%-0.12
-1423.04%-1.18
-25.56%-0.11
-2093.21%-2.36
465.38%0.37
19.34%-0.08
-46.42%-0.08
65.04%-0.11
---0.10
---0.10
---0.06
---0.31
----
----
----
Revenue
--7.00K
--7.00K
--18.00K
--7.00K
----
----
----
----
----
----
----
----
----
--50.00K
----
--50.00K
----
Net Profit
-80.51%-2.29M
119.35%5.25M
-134.61%-1.47M
-1513.72%-14.35M
-31.70%-1.27M
-2094.98%-27.11M
465.49%4.25M
19.33%-889.00K
-46.42%-962.00K
65.04%-1.23M
46.43%-1.16M
-50.55%-1.10M
1.79%-657.00K
---3.53M
---2.17M
---732.00K
---669.00K
Net Margin
---32628.57%
--74785.71%
---8194.44%
---205028.57%
----
----
----
----
----
----
----
----
----
---7074.00%
----
----
----
Gross Margin
--100.00%
---4028.57%
---1505.56%
---4171.43%
----
----
----
----
----
----
----
----
----
--100.00%
----
----
----
Debt to assets ratio
-85.84%6.46%
-91.85%3.57%
632.94%125.66%
284.59%117.27%
58.14%45.59%
61.75%43.76%
-34.41%17.15%
19.31%30.49%
21.25%28.83%
25.90%27.05%
--26.14%
--25.56%
--23.78%
--21.49%
----
----
----
Revenue
--7.00K
--7.00K
--18.00K
--7.00K
----
----
----
----
----
----
----
----
----
--50.00K
----
--50.00K
----
Operating profit
-126.63%-2.29M
15.54%-739.00K
15.88%-948.00K
-84.19%-1.15M
-31.00%-1.01M
23.18%-875.00K
-4.55%-1.13M
37.90%-626.00K
3.99%-771.00K
-15.05%-1.14M
-21.26%-1.08M
-34.40%-1.01M
-13.26%-803.00K
---990.00K
---889.00K
---750.00K
---709.00K
Net Profit
-80.51%-2.29M
119.35%5.25M
-134.61%-1.47M
-1513.72%-14.35M
-31.70%-1.27M
-2094.98%-27.11M
465.49%4.25M
19.33%-889.00K
-46.42%-962.00K
65.04%-1.23M
46.43%-1.16M
-50.55%-1.10M
1.79%-657.00K
---3.53M
---2.17M
---732.00K
---669.00K
Current assets
-82.73%377.00K
-83.21%411.00K
-71.12%917.00K
382.41%1.48M
551.64%2.18M
637.35%2.45M
533.73%3.17M
-11.78%307.00K
-13.88%335.00K
172.13%332.00K
35.77%501.00K
--348.00K
21.18%389.00K
--122.00K
--369.00K
----
--321.00K
Total current liabilities
-83.08%1.69M
-88.12%1.16M
1990.77%23.79M
59.82%23.17M
-28.03%9.97M
-25.51%9.79M
-90.72%1.14M
20.27%14.50M
23.24%13.86M
24.01%13.14M
31.38%12.27M
--12.05M
-15.09%11.24M
--10.59M
--9.34M
----
--13.24M
Total assets
-14.79%17.09M
-14.22%17.41M
-61.01%18.21M
-56.80%19.06M
-54.80%20.05M
-54.54%20.29M
3.58%46.70M
-4.07%44.12M
-4.20%44.36M
-4.01%44.63M
-11.00%45.08M
--45.99M
-17.73%46.30M
--46.50M
--50.66M
----
--56.28M
Total liabilities
-82.06%2.38M
-85.83%1.85M
119.22%27.06M
49.09%26.44M
-22.53%13.24M
-20.27%13.05M
-20.37%12.34M
15.98%17.73M
18.05%17.09M
18.39%16.37M
7.27%15.50M
--15.29M
-15.32%14.48M
--13.83M
--14.45M
----
--17.10M
Total equity
116.02%14.71M
114.94%15.55M
-125.77%-8.85M
-127.97%-7.38M
-75.02%6.81M
-74.39%7.24M
16.13%34.35M
-14.07%26.38M
-14.32%27.26M
-13.49%28.26M
-18.30%29.58M
--30.70M
-18.78%31.82M
--32.67M
--36.21M
----
--39.18M
Net operating income
31.96%-464.00K
107.88%99.00K
52.30%-613.00K
-4.20%-694.00K
4.21%-682.00K
-190.07%-1.26M
-91.51%-1.28M
9.14%-666.00K
29.78%-712.00K
-19.28%-433.00K
16.33%-671.00K
-34.74%-733.00K
-90.24%-1.01M
---363.00K
---802.00K
---544.00K
---533.00K
Net investment
-200.00%-1.00K
--1.00K
0.00%1.00K
-100.00%0.00
--1.00K
-100.00%0.00
200.00%1.00K
109.09%1.00K
----
100.36%1.00K
0.00%-1.00K
-134.38%-11.00K
96.19%-4.00K
---275.00K
---1.00K
--32.00K
---105.00K
Net financing
--482.00K
-118.57%-109.00K
----
-100.00%0.00
----
153.02%587.00K
354.02%3.95M
-10.86%665.00K
-29.89%713.00K
-56.96%232.00K
12.55%870.00K
22.30%746.00K
62.72%1.02M
--539.00K
--773.00K
--610.00K
--625.00K

FAQs

What is the total revenue of Impact Biomedical Inc?

According to Impact Biomedical Inc's FY2025 earnings report, its total revenue reached 32.00K, with a year-on-year change of 32.00K.

What are the current assets of Impact Biomedical Inc?

According to Impact Biomedical Inc's FY2025 earnings report, its current assets were 411.00K, with a year-on-year change of -83.21.

What are the total assets of Impact Biomedical Inc?

According to Impact Biomedical Inc's FY2025 earnings report, its total assets of Impact Biomedical Inc were 17.41M, with a year-on-year change of -14.22.

What are the total liabilities of Impact Biomedical Inc?

According to Impact Biomedical Inc's FY2025 earnings report, its total liabilities of Impact Biomedical Inc were 1.85M, with a year-on-year change of -85.83.

What is the total equity of Impact Biomedical Inc?

According to Impact Biomedical Inc's FY2025 earnings report, its total equity of Impact Biomedical Inc was 15.55M, with a year-on-year change of 114.94.

What is the net operating income of Impact Biomedical Inc?

According to Impact Biomedical Inc's FY2025 earnings report, its net operating income of Impact Biomedical Inc was -3.85M, with a year-on-year change of -13.36.

What is the net investment of Impact Biomedical Inc?

According to Impact Biomedical Inc's FY2025 earnings report, its net investment of Impact Biomedical Inc was 3.00K, with a year-on-year change of 50.00.

What is the net financing of Impact Biomedical Inc?

According to Impact Biomedical Inc's FY2025 earnings report, its net financing of Impact Biomedical Inc was -109.00K, with a year-on-year change of -102.25.

What is the Earnings Per Share (EPS) of Impact Biomedical Inc?

According to Impact Biomedical Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.38, with a year-on-year change of 83.66.

What is the net income of Impact Biomedical Inc?

According to Impact Biomedical Inc's FY2025 earnings report, its net income was -11.84M, with a year-on-year change of 52.09.

What is the debt-to-asset ratio of Impact Biomedical Inc?

According to Impact Biomedical Inc's FY2025 earnings report, its debt-to-asset ratio was 3.57, with a year-on-year change of -91.85.

What is the Return on Equity (ROE) of Impact Biomedical Inc?

According to Impact Biomedical Inc's FY2025 earnings report, its Return on Equity (ROE) was -140.86, with a year-on-year change of 16.31.

What is the Return on Assets (ROA) of Impact Biomedical Inc?

According to Impact Biomedical Inc's FY2025 earnings report, its Return on Assets (ROA) was -62.98, with a year-on-year change of 17.46.

What is the operating profit of Impact Biomedical Inc?

According to Impact Biomedical Inc's FY2025 earnings report, its operating profit was -3.85M, with a year-on-year change of -13.36.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.